Home Medicine Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
Article
Licensed
Unlicensed Requires Authentication

Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus

  • Milena Brugnara , Rossella Gaudino , Silvana Tedeschi , Marie-Louise Syrèn , Silverio Perrotta , Evelina Maines and Marco Zaffanello EMAIL logo
Published/Copyright: May 13, 2014

Abstract

We report the case of an infant boy with polyuria and a familial history of central diabetes insipidus. Laboratory blood tests disclosed hypokalemia, metabolic alkalosis, hyperreninemia, and hyperaldosteronism. Plasma magnesium concentration was slightly low. Urine analysis showed hypercalciuria, hyposthenuria, and high excretion of potassium. Such findings oriented toward type III Bartter syndrome (BSIII). Direct sequencing of the CLCNKB gene revealed no disease-causing mutations. The water deprivation test was positive. Magnetic resonance imaging showed a lack of posterior pituitary hyperintensity. Finally, direct sequencing of the AVP-NPII gene showed a point mutation (c.1884G>A) in a heterozygous state, confirming an autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI). This condition did not explain the patient’s phenotype; thus, we investigated for Gitelman syndrome (GS). A direct sequencing of the SLC12A3 gene showed c.269A>C and c.1205C>A new mutations. In conclusion, the patient had a genetic combination of GS and adFNDI with a BSIII-like phenotype.


Corresponding author: Marco Zaffanello, Pediatric Division, Department of Life and Reproduction Sciences, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy, E-mail:

References

1. Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000;11:1449–59.10.1681/ASN.V1181449Search in Google Scholar PubMed

2. Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 2008;3:22.10.1186/1750-1172-3-22Search in Google Scholar PubMed PubMed Central

3. Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol 2009;24:697–705.10.1007/s00467-008-0968-xSearch in Google Scholar PubMed PubMed Central

4. Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011;26:1789–802.10.1007/s00467-011-1871-4Search in Google Scholar PubMed PubMed Central

5. Christensen JH, Siggaard C, Corydon TJ, deSanctis L, Kovacs L, et al. Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur J Hum Genet 2004;12:44–51.10.1038/sj.ejhg.5201086Search in Google Scholar PubMed

6. Russell TA, Ito M, Ito M, Yu RN, Martinson FA, et al. A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J Clin Invest 2003;112:1697–706.10.1172/JCI200318616Search in Google Scholar

7. Metz MP. Determining urinary calcium/creatinine cut-offs for the pediatric population using published data. Ann Clin Biochem 2006;43:398–401.10.1258/000456306778520106Search in Google Scholar PubMed

8. Ito M, Jameson JL, Ito M. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus: cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 1997;99:1897–905.10.1172/JCI119357Search in Google Scholar PubMed PubMed Central

9. Elias PC, Elias LL, Torres N, Moreira AC, Antunes-Rodrigues J, et al. Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol (Oxf) 2003;59:511–8.10.1046/j.1365-2265.2003.01834.xSearch in Google Scholar PubMed

10. Flück CE, Deladoëy J, Nayak S, Zeller O, Kopp P, et al. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Δ/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). Eur J Endocrinol 2001;145:439–44.10.1530/eje.0.1450439Search in Google Scholar PubMed

11. Jeck N, Schlingmann KP, Reinalter SC, Kömhoff M, Peters M, et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 2005;288:782–95.10.1152/ajpregu.00600.2004Search in Google Scholar PubMed

12. Colussi G. Bartter syndrome. Orphanet encyclopedia, 2007.Search in Google Scholar

13. Lin SH, Shiang JC, Huang CC, Yang SS, Hsu YJ, et al. Phenotype and genotype analysis in Chinese patients with Gitelman’s syndrome. J Clin Endocrinol Metab 2005;90:2500–7.10.1210/jc.2004-1905Search in Google Scholar PubMed

14. Reissinger A, Ludwig M, Utsch B, Prömse A, Baulmann J, et al. Novel NCCT gene mutations as a cause of Gitelman syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res 2002;25:354–62.10.1159/000068695Search in Google Scholar PubMed

15. Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol 2011;22:693–703.10.1681/ASN.2010090907Search in Google Scholar PubMed PubMed Central

16. Frank E, Landgraf R. The vasopressin system – from antidiuresis to psychopathology. Eur J Pharmacol 2008;583:226–42.10.1016/j.ejphar.2007.11.063Search in Google Scholar PubMed

Received: 2014-1-30
Accepted: 2014-4-7
Published Online: 2014-5-13
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Downloaded on 12.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0052/html
Scroll to top button